413 related articles for article (PubMed ID: 17854227)
61. Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery.
Xiang D; Shigdar S; Bean AG; Bruce M; Yang W; Mathesh M; Wang T; Yin W; Tran PH; Al Shamaileh H; Barrero RA; Zhang PZ; Li Y; Kong L; Liu K; Zhou SF; Hou Y; He A; Duan W
Theranostics; 2017; 7(17):4071-4086. PubMed ID: 29158811
[TBL] [Abstract][Full Text] [Related]
62. Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells.
An Y; Hu Y; Li X; Li Z; Duan J; Yang XD
Sci Rep; 2019 May; 9(1):7343. PubMed ID: 31089250
[TBL] [Abstract][Full Text] [Related]
63. Doxorubicin-conjugated D-glucosamine- and folate- bi-functionalised InP/ZnS quantum dots for cancer cells imaging and therapy.
Ranjbar-Navazi Z; Eskandani M; Johari-Ahar M; Nemati A; Akbari H; Davaran S; Omidi Y
J Drug Target; 2018 Mar; 26(3):267-277. PubMed ID: 28795849
[TBL] [Abstract][Full Text] [Related]
64. Turn-on theranostic fluorescent nanoprobe by electrostatic self-assembly of carbon dots with doxorubicin for targeted cancer cell imaging, in vivo hyaluronidase analysis, and targeted drug delivery.
Gao N; Yang W; Nie H; Gong Y; Jing J; Gao L; Zhang X
Biosens Bioelectron; 2017 Oct; 96():300-307. PubMed ID: 28511113
[TBL] [Abstract][Full Text] [Related]
65. Robust and specific ratiometric biosensing using a copper-free clicked quantum dot-DNA aptamer sensor.
Zhang H; Feng G; Guo Y; Zhou D
Nanoscale; 2013 Nov; 5(21):10307-15. PubMed ID: 24056667
[TBL] [Abstract][Full Text] [Related]
66. Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates.
Lee IH; An S; Yu MK; Kwon HK; Im SH; Jon S
J Control Release; 2011 Nov; 155(3):435-41. PubMed ID: 21641946
[TBL] [Abstract][Full Text] [Related]
67. A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer.
Kim D; Jeong YY; Jon S
ACS Nano; 2010 Jul; 4(7):3689-96. PubMed ID: 20550178
[TBL] [Abstract][Full Text] [Related]
68. Anti-Proliferative Effect of Doxorubicin-Loaded AS1411 Aptamer on Colorectal Cancer Cell.
Lohlamoh W; Soontornworajit B; Rotkrua P
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2209-219. PubMed ID: 34319045
[TBL] [Abstract][Full Text] [Related]
69. Quantum dots as simultaneous acceptors and donors in time-gated Förster resonance energy transfer relays: characterization and biosensing.
Algar WR; Wegner D; Huston AL; Blanco-Canosa JB; Stewart MH; Armstrong A; Dawson PE; Hildebrandt N; Medintz IL
J Am Chem Soc; 2012 Jan; 134(3):1876-91. PubMed ID: 22220737
[TBL] [Abstract][Full Text] [Related]
70. Aptamers with Self-Loading Drug Payload and pH-Controlled Drug Release for Targeted Chemotherapy.
Zeng Z; Qi J; Wan Q; Zu Y
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452182
[TBL] [Abstract][Full Text] [Related]
71. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
[TBL] [Abstract][Full Text] [Related]
72. Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.
Abnous K; Danesh NM; Ramezani M; Charbgoo F; Bahreyni A; Taghdisi SM
Expert Opin Drug Deliv; 2018 Nov; 15(11):1045-1052. PubMed ID: 30269603
[TBL] [Abstract][Full Text] [Related]
73. CuInS(2) quantum dots/poly((L)-glutamic acid)-drug conjugates for drug delivery and cell imaging.
Gao X; Liu Z; Lin Z; Su X
Analyst; 2014 Feb; 139(4):831-6. PubMed ID: 24418901
[TBL] [Abstract][Full Text] [Related]
74. Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy.
Chen Z; Tai Z; Gu F; Hu C; Zhu Q; Gao S
Eur J Pharm Biopharm; 2016 Oct; 107():130-41. PubMed ID: 27393562
[TBL] [Abstract][Full Text] [Related]
75. A fluorescent polymeric quantum dot/aptamer superstructure and its application for imaging of cancer cells.
Jie G; Zhao Y; Qin Y
Chem Asian J; 2014 May; 9(5):1261-4. PubMed ID: 24616365
[TBL] [Abstract][Full Text] [Related]
76. Aptamer-based detection of epithelial tumor marker mucin 1 with quantum dot-based fluorescence readout.
Cheng AK; Su H; Wang YA; Yu HZ
Anal Chem; 2009 Aug; 81(15):6130-9. PubMed ID: 19572710
[TBL] [Abstract][Full Text] [Related]
77. Targeted delivery of chemotherapy agents using a liver cancer-specific aptamer.
Meng L; Yang L; Zhao X; Zhang L; Zhu H; Liu C; Tan W
PLoS One; 2012; 7(4):e33434. PubMed ID: 22558072
[TBL] [Abstract][Full Text] [Related]
78. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
[TBL] [Abstract][Full Text] [Related]
79. Doxorubicin conjugated NaYF(4):Yb(3+)/Tm(3+) nanoparticles for therapy and sensing of drug delivery by luminescence resonance energy transfer.
Dai Y; Yang D; Ma P; Kang X; Zhang X; Li C; Hou Z; Cheng Z; Lin J
Biomaterials; 2012 Nov; 33(33):8704-13. PubMed ID: 22938822
[TBL] [Abstract][Full Text] [Related]
80. CD30 aptamer-functionalized PEG-PLGA nanoparticles for the superior delivery of doxorubicin to anaplastic large cell lymphoma cells.
Luo X; Yang Y; Kong F; Zhang L; Wei K
Int J Pharm; 2019 Jun; 564():340-349. PubMed ID: 31002934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
